Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Soiken Holdings Inc
2385Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for pharmaceutical clinical research and epidemiology studies; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. The company was incorporated in 1994 and is headquartered in Toyonaka, Japan. Address: Senri Life Science Center, Toyonaka, Japan, 560-0082
Analytics
Preço Alvo de Wall Street
92 445.3 JPYRácio P/E
–Rendimento de dividendos
3.65 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave 2385
Análise de Dividendos 2385
Crescimento de dividendos em 5 anos
150 %Crescimento contínuo
–Taxa de pagamento em média de 5 anos
20 %Histórico de Dividendos 2385
Avaliação de ações 2385
Relatório 2385
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |